Phosplatin Therapeutics LLC-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Phosplatin Therapeutics LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014198
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Phosplatin Therapeutics LLC (Phosplatin Therapeutics) is a drug development company that carries out the clinical development of phosphaplatins products. The company develops small-molecule compounds which are used for the treatment of cancer. It has collaborations with various contract research organizations, pharmaceutical companies and universities across various countries to study the mechanism of action of its lead drug candidate PT-112 in advanced solid tumors. The company markets its products through its network of distributors across the US. Phosplatin Therapeutics is headquartered in New York, the US.

Phosplatin Therapeutics LLC – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Phosplatin Therapeutics LLC, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Phosplatin Therapeutics LLC, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Phosplatin Therapeutics LLC, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Phosplatin Therapeutics LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Phosplatin Therapeutics LLC, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Phosplatin Therapeutics LLC, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Phosplatin Therapeutics Enters into Agreement with Pfizer and Merck 10
Licensing Agreements 11
Phosplatin Therapeutics Enters into Licensing Agreement with SciClone Pharma 11
Ohio University Enters Into Licensing Agreement With Phosplatin Therapeutics 12
Phosplatin Therapeutics LLC – Key Competitors 13
Phosplatin Therapeutics LLC – Key Employees 14
Phosplatin Therapeutics LLC – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
Phosplatin Therapeutics LLC, Pharmaceuticals & Healthcare, Key Facts 2
Phosplatin Therapeutics LLC, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Phosplatin Therapeutics LLC, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Phosplatin Therapeutics LLC, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Phosplatin Therapeutics LLC, Deals By Therapy Area, 2011 to YTD 2017 8
Phosplatin Therapeutics LLC, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Phosplatin Therapeutics Enters into Agreement with Pfizer and Merck 10
Phosplatin Therapeutics Enters into Licensing Agreement with SciClone Pharma 11
Ohio University Enters Into Licensing Agreement With Phosplatin Therapeutics 12
Phosplatin Therapeutics LLC, Key Competitors 13
Phosplatin Therapeutics LLC, Key Employees 14

★海外企業調査レポート[Phosplatin Therapeutics LLC-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Siliconware Precision Industries Co., Ltd.:企業の戦略的SWOT分析
    Siliconware Precision Industries Co., Ltd. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors an …
  • Concur Technologies, Inc.:企業の戦略的SWOT分析
    Concur Technologies, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Alembic Pharmaceuticals Ltd (APLLTD):製薬・医療:M&Aディール及び事業提携情報
    Summary Alembic Pharmaceuticals Ltd (APL) is a pharmaceutical company which manufactures and markets generic pharmaceutical products. The company’s active pharmaceutical ingredients include macrolides, NSAIDs, and other drugs. It also offers branded formulations in the areas of antibiotics and antib …
  • Anek Lines SA:企業の戦略・SWOT・財務情報
    Anek Lines SA - Strategy, SWOT and Corporate Finance Report Summary Anek Lines SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Chevron Corporation (CVX)-エネルギー分野:企業M&A・提携分析
    Summary Chevron Corporation (Chevron) is an integrated oil and gas company. It operates in the oil and gas value chain from exploration and production, storage and pipeline transportation to refining, marketing and distribution of oil and gas products. Chevron explores for produces and transports cr …
  • Empresa Electrica Corani SA (COR1U):電力:M&Aディール及び事業提携情報
    Summary Empresa Electrica Corani SA (Empresa Electrica), a subsidiary of Empresa Nacional de Electricidad Bolivia, is a renewable energy company that develops and operates hydroelectric power plants and wind farms. The company offers operation and maintenance, project development, and technical serv …
  • Jubilant Life Sciences Ltd (JUBILANT):製薬・医療:M&Aディール及び事業提携情報
    Summary Jubilant Life Sciences Ltd (Jubilant) is an integrated pharmaceutical and life sciences company that provides pharmaceuticals, life science ingredients and drug discovery solutions. The company’s product portfolio includes radiopharmaceuticals, allergy therapy products, active pharmaceutical …
  • Mega Uranium Ltd. (MGA):企業の財務・戦略的SWOT分析
    Mega Uranium Ltd. (MGA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Caesars Entertainment Corporation:企業の戦略・SWOT・財務情報
    Caesars Entertainment Corporation - Strategy, SWOT and Corporate Finance Report Summary Caesars Entertainment Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Samyang Comtech Co., Ltd.:企業の戦略・SWOT・財務情報
    Samyang Comtech Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Samyang Comtech Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Rexel S.A.:戦略・SWOT・企業財務分析
    Rexel S.A. - Strategy, SWOT and Corporate Finance Report Summary Rexel S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Newpark Resources Inc (NR):企業の財務・戦略的SWOT分析
    Newpark Resources Inc (NR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Aubert & Duval:企業の戦略・SWOT・財務情報
    Aubert & Duval - Strategy, SWOT and Corporate Finance Report Summary Aubert & Duval - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Rexahn Pharmaceuticals Inc:企業のM&A・事業提携・投資動向
    Rexahn Pharmaceuticals Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Rexahn Pharmaceuticals Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • Karambunai Corporation Berhad:企業の戦略・SWOT・財務分析
    Karambunai Corporation Berhad - Strategy, SWOT and Corporate Finance Report Summary Karambunai Corporation Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • American Science & Engineering, Inc.:企業の戦略・SWOT・財務情報
    American Science & Engineering, Inc. - Strategy, SWOT and Corporate Finance Report Summary American Science & Engineering, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Indigo Biosciences Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Indigo Biosciences Inc (Indigo) is a provider of preclinical contract research services. The company’s products include assay kit platforms and formats, nuclear receptor, signaling pathway, and cell viability assay products, mitochondrial function products, and luciferase detection reagents. …
  • TheraDiag SA (ALTER):製薬・医療:M&Aディール及び事業提携情報
    Summary Theradiag SA (Theradiag), formerly Biomedical Diagnostics SA, is a biotechnology company that develops, manufactures, and markets vitro diagnostic products. The company offers product for the diagnostics of auto-immune diseases, allergies and infectious diseases. It develops product panels f …
  • INFINITT Healthcare Co., Ltd (071200):企業の財務・戦略的SWOT分析
    INFINITT Healthcare Co., Ltd (071200) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • A.H.A International Co., Ltd.:戦略・SWOT・企業財務分析
    A.H.A International Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary A.H.A International Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆